Home > Insider Trading > Filing (0001209191-15-034053)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1348911	Carbylan Therapeutics Inc.	CBYL	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1198325	Daniel Janney	One Embarcadero Center, Suite 3700 San Francisco CA 94111	No	No	Yes	No
1282889	Acmp Iv Llc	C/O Acp Iv, L.p. One Embarcadero Center, Suite 3700 San Francisco CA 94111	No	No	Yes	No
1282908	Acp Iv, L.p.	One Embarcadero Center, Suite 3700 San Francisco CA 94111	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-04-14	727,590	$0.00	727,590	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2015-04-14	1,981,124	$0.00	2,708,714	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2015-04-14	424,346	$0.00	3,133,060	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2015-04-14	332,990	$0.00	3,466,050	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2015-04-14	877,500	$5.00	4,343,550	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2015-04-14	727,590	$0.00	727,590	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2015-04-14	1,981,124	$0.00	1,981,124	$0.00
Common Stock	Convertible Promissory Note	Disposition	2015-04-14	424,346	$0.00	424,346	$0.00
Common Stock	Convertible Promissory Note	Disposition	2015-04-14	332,990	$0.00	332,990	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Upon the closing of the Issuer's initial public offering, each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into Common Stock on a one for one basis without payment or further consideration, and has no expiration date.
These securities are held by ACP IV, L.P ("ACP IV"). Daniel S. Janney and Guy P. Nohra are directors of ACMP IV, LLC, the general partner of ACP IV and disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein.
The Convertible Promissory Note is convertible into the number of shares of the Issuer's Common Stock equal to the quotient obtained by dividing the entire principal amount and 184 days of accrued interest on the Convertible Promissory Note by 80% of the initial public offering price of $5.00 per share of the Issuer's Common Stock, automatically upon the closing of the Issuer's initial public offering, and has no expiration date.
The Convertible Promissory Note is convertible into the number of shares of the Issuer's Common Stock equal to the quotient obtained by dividing the entire principal amount and 41 days of accrued interest on the Convertible Promissory Note by 80% of the initial public offering price of $5.00 per share of the Issuer's Common Stock, automatically upon the closing of the Issuer's initial public offering, and has no expiration date.